-
-
-
-
-
-
-
Bicara Therapeutics Inc. (BCAX) Reports Q1 Loss of $0.93
-
-
-
-
-
-
-
Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens: Attractive
-
-
-
-
-
-
-
Here's the list of top biotech stocks to own for 2026
-
-
-
-
-
-
-
Bicara Therapeutics (BCAX) files $400M mixed shelf
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
-
-
-
-
-
-
Bicara Therapeutics Inc. (BCAX) Reports Q1 Loss of $0.68
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
430,616 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

